These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8991646)

  • 1. Antibody response of monkeys to invasion plasmid antigen D after infection with Shigella spp.
    Oaks EV; Picking WD; Picking WL
    Clin Diagn Lab Immunol; 1996 Mar; 3(2):242-5. PubMed ID: 8991646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.
    Formal SB; Oaks EV; Olsen RE; Wingfield-Eggleston M; Snoy PJ; Cogan JP
    J Infect Dis; 1991 Sep; 164(3):533-7. PubMed ID: 1869840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the functional B-cell epitopes of
    Li S; Zhang W
    Appl Environ Microbiol; 2024 Aug; 90(8):e0098824. PubMed ID: 39082807
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum IgG antibody responses to Shigella invasion plasmid-coded antigens detected by immunoblot.
    Li A; Zhao CR; Ekwall E; Lindberg AA
    Scand J Infect Dis; 1994; 26(4):435-45. PubMed ID: 7984976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp.
    Oaks EV; Hale TL; Formal SB
    Infect Immun; 1986 Jul; 53(1):57-63. PubMed ID: 3721580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration of milk secretory immunoglobulin A against Shigella virulence plasmid-associated antigens as a predictor of symptom status in Shigella-infected breast-fed infants.
    Hayani KC; Guerrero ML; Morrow AL; Gomez HF; Winsor DK; Ruiz-Palacios GM; Cleary TG
    J Pediatr; 1992 Dec; 121(6):852-6. PubMed ID: 1447644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broadly protective Shigella vaccine based on type III secretion apparatus proteins.
    Martinez-Becerra FJ; Kissmann JM; Diaz-McNair J; Choudhari SP; Quick AM; Mellado-Sanchez G; Clements JD; Pasetti MF; Picking WL
    Infect Immun; 2012 Mar; 80(3):1222-31. PubMed ID: 22202122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shigella flexneri invasion plasmid antigens B and C: epitope location and characterization with monoclonal antibodies.
    Mills JA; Buysse JM; Oaks EV
    Infect Immun; 1988 Nov; 56(11):2933-41. PubMed ID: 2459066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes.
    Heine SJ; Diaz-McNair J; Andar AU; Drachenberg CB; van de Verg L; Walker R; Picking WL; Pasetti MF
    J Immunol; 2014 Feb; 192(4):1630-40. PubMed ID: 24453241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine.
    Martinez-Becerra FJ; Chen X; Dickenson NE; Choudhari SP; Harrison K; Clements JD; Picking WD; Van De Verg LL; Walker RI; Picking WL
    Infect Immun; 2013 Dec; 81(12):4470-7. PubMed ID: 24060976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of three epitopic regions on invasion plasmid antigen C by immune sera of rhesus monkeys infected with Shigella flexneri 2a.
    Turbyfill KR; Joseph SW; Oaks EV
    Infect Immun; 1995 Oct; 63(10):3927-35. PubMed ID: 7558301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IpaD of Shigella flexneri is independently required for regulation of Ipa protein secretion and efficient insertion of IpaB and IpaC into host membranes.
    Picking WL; Nishioka H; Hearn PD; Baxter MA; Harrington AT; Blocker A; Picking WD
    Infect Immun; 2005 Mar; 73(3):1432-40. PubMed ID: 15731041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of epitope and surface-exposed domains of Shigella flexneri invasion plasmid antigen D (IpaD).
    Turbyfill KR; Mertz JA; Mallett CP; Oaks EV
    Infect Immun; 1998 May; 66(5):1999-2006. PubMed ID: 9573082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface presentation of Shigella flexneri invasion plasmid antigens requires the products of the spa locus.
    Venkatesan MM; Buysse JM; Oaks EV
    J Bacteriol; 1992 Mar; 174(6):1990-2001. PubMed ID: 1312536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.
    Heine SJ; Diaz-McNair J; Martinez-Becerra FJ; Choudhari SP; Clements JD; Picking WL; Pasetti MF
    Vaccine; 2013 Jun; 31(28):2919-29. PubMed ID: 23644075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine.
    Turbyfill KR; Hartman AB; Oaks EV
    Infect Immun; 2000 Dec; 68(12):6624-32. PubMed ID: 11083774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An approach to chimeric subunit immunogen provides efficient protection against toxicity, type III and type v secretion systems of Shigella.
    Felegary A; Nazarian S; Kordbacheh E; Fathi J; Minae ME
    Int Immunopharmacol; 2021 Nov; 100():108132. PubMed ID: 34508943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplexed immunoassay to assess Shigella-specific antibody responses.
    Kaminski RW; Clarkson K; Kordis AA; Oaks EV
    J Immunol Methods; 2013 Jul; 393(1-2):18-29. PubMed ID: 23583496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antibody responses against shigella lipopolysaccharides and invasion plasmid-coded antigens in shigella infected Swedish patients.
    Li A; Rong ZC; Ekwall E; Forsum U; Lindberg AA
    Scand J Infect Dis; 1993; 25(5):569-77. PubMed ID: 8284641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.